Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 3.15B | 3.07B | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 3.15B | 3.07B | |
| Cost of Revenue | -- | -- | 1.74B | 1.72B | |
| Gross Profit | -- | -- | 1.41B | 1.34B | |
| SG&A Expenses | -- | -- | 723.11M | 703.96M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | 34.24M | 24.44M | |
| Total Operating Expenses | -- | -- | 2.66B | 2.61B | |
| Operating Income | -- | -- | 490.51M | 456.47M | |
| Income Before Tax | -- | -- | 309.05M | 274.46M | |
| Income Tax Expenses | -- | -- | 63.17M | 54.01M | |
| Earnings from Continuing Operations | -- | -- | 245.88 | 220.45 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -1.42M | -2.49M | |
| Net Income | -- | -- | 244.47M | 217.96M | |
| EBIT | -- | -- | 490.51M | 456.47M | |
| EBITDA | -- | -- | 757.15M | 714.89M | |
| EPS Basic | -- | -- | 2.51 | 2.25 | |
| Normalized Basic EPS | -- | -- | 1.17 | 0.95 | |
| EPS Diluted | -- | -- | 2.51 | 2.25 | |
| Normalized Diluted EPS | -- | -- | 1.17 | 0.95 | |
| Average Basic Shares Outstanding | -- | -- | 390.39M | 387.73M | |
| Average Diluted Shares Outstanding | -- | -- | 390.39M | 387.73M | |
| Dividend Per Share | -- | -- | 0.74 | 0.74 | |
| Payout Ratio | -- | -- | 31.15% | 33.14% | |